Connect with us

Life Sciences

Startups across NC raise more than $40M so far in November

Startups across North Carolina have raised more than $35 million so far in November, according to a review of SEC filings. Here’s the list.
The post Startups…

Published

on

This article was originally published by WRAL Techwire

RESEARCH TRIANGLE PARK – Startups across North Carolina have raised more than $35 million so far in November, according to a review of SEC filings.

Here are the filings as of Nov. 25, including company name, business focus, the amount of money raised, and the date of the filing. All are “new filings” so the amount of money listed is new capital.

Paymints.io Corp (Other Technology)
$3,000,000
2022-11-22

Allstacks, Inc. (Other Technology)
$12,692,420
2022-11-21

METABOLON, INC (Other Health Care)
$10,043,517
2022-11-10

410 Medical, Inc. (Other Health Care)
$10,343,715
2022-11-10

Offline Media, Inc. (Other)
$1,680,102
2022-11-01

Hip eCommerce, Inc. (Other)
$1,100,000
2022-11-04

EQUITY SHIFT, INC. (Other Banking and Financial Services)
$500,000
2022-11-17

OCARO PHARMACEUTICALS INC. (Pharmaceuticals)
$610,000
2022-11-15

Hidden Ships Distillery, LLC (Manufacturing)
$187,500
2022-11-18

Flux Hybrids, Inc (Other Technology)
$122,000
2022-11-08

The post Startups across NC raise more than $40M so far in November first appeared on WRAL TechWire.


pharmaceuticals

Life Sciences

Wittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner

The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….

Continue Reading

Trending